Pharmacutical Pharmaceutical drug Delivery Market | Page 2

REPORT DESCRIPTION
Pharmaceutical Drug Delivery Market – Overview
Increasing approval of new drugs from U.S. FDA is expected to drive growth of the global pharmaceutical
drug delivery market. For instance, in April 2019, the U.S. Food and Drug Administration (FDA)
announced the approval of Duobrii (contains-halobetasol propionate and tazarotene), which is used for the
treatment of plaque psoriasis. It is manufactured by Ortho Dermatogics Company.
Furthermore, new product launches is expected to boost the global pharmaceutical drug delivery market.
For instance, in August 2018, Sanofi Genzyme launched new drug (Aubagio) for the treatment of multiple
sclerosis. Aubagio offers once-a-day treatment and ease of convenience for the patient. Moreover, in April
2019, Pfizer launched trastuzumab (trazimera) for the treatment of metastatic HER2 (Human Epidermal
Growth Factor2)-positive breast cancer and HER2-positive metastatic gastric cancer. Hence, these products
are expected to boost the global pharmaceutical drug delivery market.